223 related articles for article (PubMed ID: 16299277)
1. Demonstration of OspC type diversity in invasive human lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response.
Earnhart CG; Buckles EL; Dumler JS; Marconi RT
Infect Immun; 2005 Dec; 73(12):7869-77. PubMed ID: 16299277
[TBL] [Abstract][Full Text] [Related]
2. Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development.
Buckles EL; Earnhart CG; Marconi RT
Clin Vaccine Immunol; 2006 Oct; 13(10):1162-5. PubMed ID: 17028218
[TBL] [Abstract][Full Text] [Related]
3. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
Lovrich SD; Jobe DA; Schell RF; Callister SM
Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749
[TBL] [Abstract][Full Text] [Related]
4. Identification of B-cell epitopes of Borrelia burgdorferi outer surface protein C by screening a phage-displayed gene fragment library.
Pulzova L; Flachbartova Z; Bencurova E; Potocnakova L; Comor L; Schreterova E; Bhide M
Microbiol Immunol; 2016 Oct; 60(10):669-677. PubMed ID: 27619624
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a unique borreliacidal epitope on the outer surface protein C of Borrelia burgdorferi.
Yang X; Li Y; Dunn JJ; Luft BJ
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):64-74. PubMed ID: 16965353
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses.
Izac JR; Camire AC; Earnhart CG; Embers ME; Funk RA; Breitschwerdt EB; Marconi RT
Vaccine; 2019 Apr; 37(17):2401-2407. PubMed ID: 30922701
[TBL] [Abstract][Full Text] [Related]
7. Development of an OspC-based tetravalent, recombinant, chimeric vaccinogen that elicits bactericidal antibody against diverse Lyme disease spirochete strains.
Earnhart CG; Buckles EL; Marconi RT
Vaccine; 2007 Jan; 25(3):466-80. PubMed ID: 16996663
[TBL] [Abstract][Full Text] [Related]
8. An octavalent lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences.
Earnhart CG; Marconi RT
Hum Vaccin; 2007; 3(6):281-9. PubMed ID: 17921702
[TBL] [Abstract][Full Text] [Related]
9. Inferring epitopes of a polymorphic antigen amidst broadly cross-reactive antibodies using protein microarrays: a study of OspC proteins of Borrelia burgdorferi.
Baum E; Randall AZ; Zeller M; Barbour AG
PLoS One; 2013; 8(6):e67445. PubMed ID: 23826301
[TBL] [Abstract][Full Text] [Related]
10. Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.
Wagner B; Freer H; Rollins A; Erb HN; Lu Z; Gröhn Y
Vet Immunol Immunopathol; 2011 Dec; 144(3-4):374-81. PubMed ID: 21890217
[TBL] [Abstract][Full Text] [Related]
11. Antibody profiling of canine IgG responses to the OspC protein of the Lyme disease spirochetes supports a multivalent approach in vaccine and diagnostic assay development.
Oliver LD; Earnhart CG; Virginia-Rhodes D; Theisen M; Marconi RT
Vet J; 2016 Dec; 218():27-33. PubMed ID: 27938705
[TBL] [Abstract][Full Text] [Related]
12. The Position of His-Tag in Recombinant OspC and Application of Various Adjuvants Affects the Intensity and Quality of Specific Antibody Response after Immunization of Experimental Mice.
Krupka M; Masek J; Barkocziova L; Turanek Knotigova P; Kulich P; Plockova J; Lukac R; Bartheldyova E; Koudelka S; Chaloupkova R; Sebela M; Zyka D; Droz L; Effenberg R; Ledvina M; Miller AD; Turanek J; Raska M
PLoS One; 2016; 11(2):e0148497. PubMed ID: 26848589
[TBL] [Abstract][Full Text] [Related]
13. C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease.
Jobe DA; Lovrich SD; Schell RF; Callister SM
Clin Diagn Lab Immunol; 2003 Jul; 10(4):573-8. PubMed ID: 12853388
[TBL] [Abstract][Full Text] [Related]
14. Identification of an ospC operator critical for immune evasion of Borrelia burgdorferi.
Xu Q; McShan K; Liang FT
Mol Microbiol; 2007 Apr; 64(1):220-31. PubMed ID: 17376084
[TBL] [Abstract][Full Text] [Related]
15. Borreliacidal OspC antibody response of canines with Lyme disease differs significantly from that of humans with Lyme disease.
Lovrich SD; La Fleur RL; Jobe DA; Johnson JC; Asp KE; Schell RF; Callister SM
Clin Vaccine Immunol; 2007 May; 14(5):635-7. PubMed ID: 17344346
[TBL] [Abstract][Full Text] [Related]
16. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.
Wagner B; Freer H; Rollins A; Erb HN
Vet Immunol Immunopathol; 2011 Apr; 140(3-4):190-8. PubMed ID: 21208663
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
Koide S; Yang X; Huang X; Dunn JJ; Luft BJ
J Mol Biol; 2005 Jul; 350(2):290-9. PubMed ID: 15935380
[TBL] [Abstract][Full Text] [Related]
18. Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC.
Jobe DA; Lovrich SD; Asp KE; Mathiason MA; Albrecht SE; Schell RF; Callister SM
Clin Vaccine Immunol; 2008 Jun; 15(6):981-5. PubMed ID: 18417666
[TBL] [Abstract][Full Text] [Related]
19. Identification of Surface Epitopes Associated with Protection against Highly Immune-Evasive VlsE-Expressing Lyme Disease Spirochetes.
Batool M; Caoili SEC; Dangott LJ; Gerasimov E; Ionov Y; Piontkivska H; Zelikovsky A; Waghela SD; Rogovskyy AS
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29866906
[TBL] [Abstract][Full Text] [Related]
20. Development and optimization of OspC chimeritope vaccinogens for Lyme disease.
Izac JR; O'Bier NS; Oliver LD; Camire AC; Earnhart CG; LeBlanc Rhodes DV; Young BF; Parnham SR; Davies C; Marconi RT
Vaccine; 2020 Feb; 38(8):1915-1924. PubMed ID: 31959423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
